Mary Jane Lim-Fat1, Katrina Roberto2, Patrick Y Wen3

  • 1Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Maryjane.limfat@sunnybrook.ca.

PubMed
概括

对脑瘤的生物标志物驱动的临床试验正在以新的设计向前推进. 这些试验旨在改善向治疗的评估,确保患者的安全性和治疗疗效.